Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.

Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers

An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.
More on this head and neck cancer trial
The Princess Royal officially opens pioneering centre for 'Darwinian' cancer drug discovery

Her Royal Highness The Princess Royal has officially opened the Centre for Cancer Drug Discovery and toured the centre to learn more about its work to overcome cancer’s ability to evolve and become resistant to treatment.
The Princess Royal's visit
'Gut bugs' can drive prostate cancer growth and treatment resistance

Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.
More about this prostate cancer study

1/3

Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Personalised treatments
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Big data research
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Our innovative approaches
Queen's Anniversary Prize

The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Queen's Anniversary Prize
Making it count

We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
Improving patient lives
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
About drug discovery